Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, today announced that an abstract...

Synchrony (NYSE: SYF) Chief Executive Officer, Margaret M. Keane, and Executive Vice President and Chief Financial Officer, Brian J. Wenzel, will participate in the Goldman Sachs US Financial...

PRA Group (Nasdaq: PRAA), a global leader in acquiring and collecting nonperforming loans, will present to investors at the Bank of America Securities 2020 Leveraged Finance Virtual Conference on...

REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology...

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that...